Vasodilatory effects of nipradilol, an α- and β-adrenergic blocker with nitric oxide releasing action, in rabbit ciliary artery

Experimental Eye Research

Volumn 75, Issue 6, 2002, Pages 669-676

  Yoshitomi, Takeshi ^a,b   Yamaji, Kazutsuna ^a,b   Ishikawa, Hitoshi ^a,b   Ohnishi, Yoshitaka ^a,b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiglaucoma agent; Ciliary artery; Nipradilol; Nitric oxide; Rabbit; adrenergic antagonist

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NIPRADILOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM ION; SCAVENGER;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CILIARY ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENITRIFICATION; DISSECTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EYE; MALE; MICROSCOPE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TONE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCALP HAIR; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

EID: 0036924944     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.2002.2061     Document Type: Article

References (25)

1. Adachi, T., Hori, S., Miyazaki, K., Takahashi, E., Nakagawa, M., Udagawa, A., Hayashi, N., Aikawa, N. and Ogawa, S. (1995). Rapid increase in plasma nitrite concentration following intravenous administration of nipradilol. Eur. J. Pharmacol. 286, 201-4.
2. Asada, H., Nanjo, T., Itoh, T., Suzuki, H. and Kuriyama, H. (1982). Effects of 3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitroxy-2H-l-bezopyran (K-351) on smooth muscle cells and neuromuscular transmission in guinea-pig vascular tissues. J. Pharmacol. Exp. Ther. 223, 560-72.
3. Chung, H. S., Harris, A., Evans, D. W., Kagemann, L., Garzozi, H. J. and Martin, B. (1999). Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv. Ophthalmol. 43(Suppl. 1): S43-S50.
4. Geijssen, H. C. and Greve, E. L. (1995). Vascular concepts in glaucoma. Curt. Opin. Ophthalmol. 6, 71-7.
5. Hayashi, E., Yoshitomi, T., Ishikawa, H., Hayashi, R. and Shimizu, K. (2000). Effects of isopropyl unoprostone onrabbit ciliary artery. Jpn. J. Ophthalmol. 44, 214-20.
6. Hayashi-Morimoto, R., Yoshitomi, T., Ishikawa, H., Hayashi, E. and Sato, Y. (1999). Effects of beta antagonists on mechanical properties in rabbit ciliary artery. Graefes Arch. Clin. Exp. Ophthalmol. 237, 661-7.
7. Hisa, H., Suzuki-Kusaba, M. and Satoh, S. (1987). Effects of K-351 on adrenergically induced renin release and renal vasoconstriction in anesthetized dogs. J. Cardiovasc. Pharmacol. 9, 1-5.
8. Kanno, M., Araie, M., Koibuchi, H. and Masuda, K. (2000). Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans. Br. J. Ophthalmol. 84, 293-9.
9. Kanno, M., Araie, M., Tomita, K. and Sawanobori, K. (1998). Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Invest. Ophthalmol. Vis. Sci. 39, 736-43.
10. Kou, K., Kuriyama, H. and Suzuki, H. (1982). Effects of 3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3nitroxy-2H-l-benzopyran (K-351) on smooth muscle cells and neuromuscular transmission in the canine mesenteric artery. Br. J. Pharmacol. 77, 679-89.
11. Kou, K. and Suzuki, H. (1983). The effects of 3,4-dihydro-8(2-hydroxy-3-isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran (K-351) and its denitrated derivative on smooth muscle cells of the dog coronary artery. Br. J. Pharmacol. 79, 285-95.
12. Marczin, N., Ryan, U. S. and Catravas, J. D. (1992). Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J. Pharmacol. Exp. Ther. 263, 170-9.
13. Masuda, K. (1996). [Current topics in glaucoma]. Nippon Ganka Gakkai Zasshi 100, 923-36.
14. Mizuno, K., Koide, T., Yoshimura, M. and Araie, M. (2001). Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Invest. Ophthalmol. Vis. Sci. 42, 688-94.
15. Mulvany, M. J. and Halpern, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41, 19-26.
16. Nagataki, S., Koseki, Y., Yamakawa, R. and Koibuchi, H. (1997). [Effect of nipradilol on aqueous flow in glaucoma patients treated with timolol]. Nippon Ganka Gakkai Zasshi 101, 252-6.
17. Nanio, T. and Kitamura, K. (1984). Actions of nipradilol (K-351), a new alpha-and beta-adrenoceptor blocker, on the rabbit portal vein. Jpn. J. Pharmacol. 35, 359-69.
18. Noguchi, K. and Sakanashi, M. (1987). Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs. Br. J. Pharmacol. 91, 411-9.
19. Ohira, A., Wada, Y., Fuiii, M., Nakamura, M., Kasuya, Y., Hamada, Y. and Shigenobu, K. (1985). Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues. Arch. Int. Pharmacodyn. Ther. 278, 61-71.
20. Okamura, T., Kitamura, Y., Uchiyama, M., Toda, M., Ayaiiki, K. and Toda, N. (1996). Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic. Pharmacology 53, 302-10.
21. Rand, M. J. and Li, C. G. (1995). Discrimination by the NO-trapping agent, carboxy-PTIO, between NO and the nitrergic transmitter but not between NO and EDRF. Br. J. Pharmacol. 116, 1906-10.
22. Sakanashi, M., Takeo, S., Ito, H., Noguchi, K., Miyamato, Y. and Higa, T. (1984). Effects of an antihypertensive agent, nipradilol, on isolated coronary artery of the dog. Pharmacology 29, 241-6.
23. Tamaki, Y., Araie, M., Tomita, K., Nagahara, M. and Tomidokoro, A. (1997). Effect of topical beta-blockers on tissue blood flow in the human optic nerve head. Curt. Eye Res. 16, 1102-10.
24. Yamamoto, T. and Kitazawa, Y. (1998). Vascular pathogenesis of normal-tension glaucoma: A possible pathogenetic factor, other than intraocular pressure, of glaucomatousoptic neuropathy. Prog. Retin Eye Res. 17, 127-43.
25. Yoshitomi, T., Ishikawa, H. and Hayashi, E. (2000). Pharmacological effects of pilocarpine on rabbit ciliary artery. Curt. Eye Res. 20, 254-9.